Cytokinetics therapeutics
WebCytokinetics takes a purpose-driven approach by leveraging our unique muscle biology expertise to engineer compounds with specific characteristics aimed at treating diseases … Web2 days ago · Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for …
Cytokinetics therapeutics
Did you know?
WebHeadquarters United States of America. Address ., 280 East Grand Avenue, South San Francisco, California, 94080. Website cytokinetics.com. Telephone 1 650 6243000. No of Employees 253. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange CYTK (NASD) Revenue (2024) $70.4M 26.2% (2024 vs 2024) EPS XXX. WebCytokinetics 14,180 followers on LinkedIn. Empowering Muscle Empowering Lives Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing ...
WebMar 10, 2024 · Cytokinetics has an analyst consensus of Strong Buy, with a price target consensus of $61.31, a 56.7% upside from current levels. In a report issued on February 28, Raymond James also maintained... WebThis Amendment No. 6 to the Agreement (this “Amendment No. 6”) is entered into as of June 11, 2013 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a ...
WebApr 11, 2024 · 12 analysts have issued twelve-month price targets for Cytokinetics' shares. Their CYTK share price forecasts range from $15.00 to $80.00. On average, they expect the company's stock price to reach $56.21 in the next year. This suggests a possible upside of 54.4% from the stock's current price. View analysts price targets for CYTK or view top ... WebFeb 22, 2024 · For Cytokinetics, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has...
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in ...
WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … eastpointe bakery eastpointe michiganWebNov 28, 2006 · Cytokinetics is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. cumberland bowling wienWebAccord Healthcare, Inc., the US subsidiary of Intas Pharmaceuticals, is a leading generic pharmaceutical company headquartered in Durham, North Carolina. Through its … eastpointe behavioral health jobsWebLandos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune disease. … eastpointe behavioral healthcareWebApr 6, 2024 · The main competitors of Cytokinetics include IVERIC bio (ISEE), Reata Pharmaceuticals (RETA), Zai Lab (ZLAB), Maravai LifeSciences (MRVI), Amicus Therapeutics (FOLD), PTC Therapeutics (PTCT), ACADIA Pharmaceuticals (ACAD), Cerevel Therapeutics (CERE), Bausch Health Companies (BHC), and Ultragenyx … cumberland bournemouth websiteWebMar 10, 2024 · Cytokinetics has an analyst consensus of Strong Buy, with a price target consensus of $61.31, a 56.7% upside from current levels. In a report issued on February … eastpointe behavioral health kinston ncWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential … eastpointe bean bag toss